Adial Pharmaceuticals, Inc - Common Stock - Mali Tablolar (NASDAQ:ADIL) | MetaTrader

Tam grafiği aç Full chart

Haberler

Adial Pharmaceuticals, AD04 için patent başvurusu yaptı

Adial Pharmaceuticals FDA öncelik programına başvurdu

Adial Pharmaceuticals AD04 için üretim partisini tamamladı

Adial Pharmaceuticals Lead Drug Fits New Policy Mood As Bipartisan Bill Signals Broader Lens On Alcohol Use Disorder - Adial Pharmaceuticals (NASDAQ:ADIL)

Adial Pharmaceuticals, Avrupa için Molteni ile çerçeve anlaşması imzaladı

Adial Pharmaceuticals signs framework deal with Molteni for Europe

EXCLUSIVE: Adial Pharma Eyes Europe Deal For Lead Drug For Alcohol Use Disrder Worth Up To $60 Million - Adial Pharmaceuticals (NASDAQ:ADIL)

Adial Pharmaceuticals hisseleri FDA politika değişikliğiyle yükseldi

Adial Pharmaceuticals stock rises on FDA policy shift

Adial Pharmaceuticals, AD04 için tek pivotal deneme yolunu değerlendiriyor

Adial Pharmaceuticals eyes single pivotal trial path for AD04

Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories! - TipRanks.com